Literature DB >> 21791829

Orthopedic management of mucopolysaccharide disease.

Klane K White1, Paul Harmatz.   

Abstract

With advances in the treatment of the mucopolysaccharidosis (MPS) disorders, musculoskeletal problems are increasingly becoming a focus of care for these patients. This review discusses the current understanding of the pathophysiology of musculoskeletal disease in MPS and its orthopedic management. Deformities of the spine, hips and extremities are common and often functionally limiting. Carpal tunnel syndrome and flexor tendon triggering are common. Surgical intervention is often required to optimize long-term function.

Entities:  

Year:  2010        PMID: 21791829     DOI: 10.3233/PRM-2010-0102

Source DB:  PubMed          Journal:  J Pediatr Rehabil Med        ISSN: 1874-5393


  20 in total

1.  Spinal cord issues in adult patients with MPS: transition of care survey.

Authors:  Kemel A Ghotme; Fernando Alvarado-Gomez; Christina Lampe; Klane K White; Martha Solano-Villareal; Roberto Giugliani; Paul R Harmatz
Journal:  Childs Nerv Syst       Date:  2018-05-27       Impact factor: 1.475

2.  The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade.

Authors:  Elizabeth M Xing; Van W Knox; Patricia A O'Donnell; Tracey Sikura; Yuli Liu; Susan Wu; Margret L Casal; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2013-04-06       Impact factor: 4.797

3.  Perioperative medullary complications in spinal and extra-spinal surgery in mucopolysaccharidosis: a case series of three patients.

Authors:  N Pauchard; C Garin; J L Jouve; P Lascombes; P Journeau
Journal:  JIMD Rep       Date:  2014-07-20

4.  Endothelial function in children and adolescents with mucopolysaccharidosis.

Authors:  Aaron S Kelly; Andrea M Metzig; Julia Steinberger; Elizabeth A Braunlin
Journal:  J Inherit Metab Dis       Date:  2012-01-10       Impact factor: 4.982

5.  Effect of neonatal gene therapy on lumbar spine disease in mucopolysaccharidosis VII dogs.

Authors:  Lachlan J Smith; John T Martin; Patricia O'Donnell; Ping Wang; Dawn M Elliott; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2012-03-29       Impact factor: 4.797

6.  Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII.

Authors:  Lachlan J Smith; Guilherme Baldo; Susan Wu; Yuli Liu; Michael P Whyte; Roberto Giugliani; Dawn M Elliott; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2012-03-30       Impact factor: 4.797

7.  Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.

Authors:  David A Stevenson; Kyle Rudser; Alicia Kunin-Batson; Ellen B Fung; David Viskochil; Elsa Shapiro; Paul J Orchard; Chester B Whitley; Lynda E Polgreen
Journal:  J Pediatr Rehabil Med       Date:  2014

Review 8.  Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.

Authors:  Sun H Peck; Margret L Casal; Neil R Malhotra; Can Ficicioglu; Lachlan J Smith
Journal:  Mol Genet Metab       Date:  2016-06-04       Impact factor: 4.797

9.  Imaging findings of mucopolysaccharidoses: a pictorial review.

Authors:  Stefano Palmucci; Giancarlo Attinà; Maria Letizia Lanza; Giuseppe Belfiore; Giuseppina Cappello; Pietro Valerio Foti; Pietro Milone; Domenico Di Bella; Rita Barone; Agata Fiumara; Giovanni Sorge; Giovanni Carlo Ettorre
Journal:  Insights Imaging       Date:  2013-05-05

10.  A Unique Case of Cervical Myelopathy in an Adult Patient with Scheie Syndrome.

Authors:  Farzam Vazifehdan; Vasilios G Karantzoulis; Robert Ebner; Vasilios G Igoumenou
Journal:  J Orthop Case Rep       Date:  2017 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.